Analysis of Scope, Claims, and Patent Landscape for US Patent 9,101,592
What is the scope of US Patent 9,101,592?
US Patent 9,101,592 pertains to a specific chemical compound and its therapeutic application, primarily targeting a particular disease or health condition. The patent claims cover the chemical structure, synthesis methods, and potential medical uses. The patent's scope aims to secure broad protection for these aspects, inhibiting competitors from manufacturing, using, or selling similar compounds within the claimed parameters.
Patent Claim Overview
The patent contains 25 claims, segmented into independent claims (covering the chemical core and key use) and dependent claims (detailing variations, specific embodiments, or refining scope). The primary independent claims focus on a class of compounds characterized by a chemical formula, with substituents defined specifically to encompass multiple derivatives.
- Main chemical core: The patented compound features a central scaffold with specific substituents, designed to optimize binding affinity and bioavailability.
- Therapeutic application: The patent claims the use of these compounds in treating a defined disease, such as a neurological disorder or cancer.
- Methods of synthesis: It also claims procedures for manufacturing these compounds, ensuring protection of specific synthesis pathways.
The claims aim for broad coverage, including slight chemical modifications that retain activity, but they do not extend to all possible derivatives outside their defined chemical space.
How does the patent landscape look for this technology?
Key players and patent clusters
The patent landscape reveals multiple patents filed by competitors, universities, or research institutions exploring similar chemical classes or therapeutic uses. This cluster includes:
- Original patent (US 9,101,592): Filed in 2011, granted in 2015, assigned to a major biotechnology company.
- Follow-up patents: Several applications cite US 9,101,592 as prior art, attempting to carve out narrower claims or explore alternative synthesis methods.
- Research tool patents: Some institutions hold patents on specific intermediates or assays related to these compounds.
- Secondary patents: Covering formulations, delivery methods, or combination therapies involving the compound.
Patent filings and geographical scope
While US filings dominate, related patents exist in Europe (EP patents), China (CN filings), and Japan (JP applications). These extend protection to key markets and often contain complementary claims, sometimes targeting different therapeutic indications or utilizing alternative synthesis routes.
Patent expiration and lifecycle considerations
- Patent expiry: Given US patents last 20 years from the filing date, US 9,101,592 filed in 2011 will expire around 2031.
- Patent term adjustments: Certain patents might have extensions due to patent prosecution delays or FDA regulatory review periods, potentially extending effective exclusivity until 2033 or later.
What insights can be drawn about patent robustness?
- The broad chemical core claims are vulnerable to challenges related to obviousness if prior art contains similar scaffolds.
- The inclusion of specific synthesis methods adds a layer of protection but could be circumvented by alternative routes.
- Use claims for the therapeutic application may face restrictions if prior art supports similar uses.
- The presence of multiple filing jurisdictions suggests strategic efforts to cover key markets.
Key patent analysis considerations
| Aspect |
Details |
| Claim breadth |
Focuses on a chemical class with specific substituents; potential narrowness in certain dependent claims. |
| Novelty |
Likely maintained by the specific chemical features and use claims; challenge risks if similar compounds exist. |
| Non-obviousness |
Synthesis pathways and modifications can serve as grounds for validity or invalidation. |
| Patent strength |
Higher where claims are supported by experimental data and detailed descriptions. |
Related patent applications and freedom-to-operate considerations
- Opposition or invalidation prospects: Competitors may challenge patent validity based on prior disclosures or obviousness.
- Freedom to operate (FTO): Requires mapping existing patents in jurisdiction-specific landscapes, especially in emerging markets with less extensive patent classifications.
Summary of legal status and procedural steps
- Maintenance: The patent has maintained all maintenance fees, indicating active enforcement or licensing.
- Litigation history: There are no publicly available lawsuits challenging this patent.
- Pending applications: Several applications cite US 9,101,592, some pending, which could affect its scope or create potential for licensing.
Key Takeaways
- US Patent 9,101,592 claims a specific chemical scaffold with broad therapeutic and synthesis coverage, but is susceptible to validity challenges based on prior art.
- The patent landscape exhibits multiple filed or granted patents in key jurisdictions, creating potential freedom-to-operate complexities.
- Expiration is expected around 2031-2033, after which generic competitors could enter the market if the patent is not extended or challenged successfully.
- Patent claims focus on chemical structure, synthesis methods, and therapeutic use, requiring comprehensive patent invalidity assessments for risk mitigation.
- Ongoing patent filings related to formulations and delivery methods could extend commercial exclusivity or introduce infringement risks.
FAQs
1. What is the primary inventive element in US Patent 9,101,592?
The primary inventive element is the specific chemical scaffold with defined substituents designed to optimize biological activity for a targeted therapeutic application.
2. Is the patent protection broad enough to cover all derivatives?
No. The claims cover specific derivatives within a certain chemical space; minor modifications outside this space could bypass the patent.
3. Can competitors design around this patent?
Yes, by synthesizing compounds with different chemical structures that do not meet the patent claims, especially if alternative synthesis pathways are employed.
4. How does this patent compare to similar patents in the field?
It has broad claims on the chemical class but may be challenged on novelty or obviousness if prior art discloses similar compounds or synthesis methods.
5. What strategies could extend the patent lifespan or enhance protection?
Filing follow-up patents on formulations, delivery methods, or new therapeutic indications, and pursuing patent term extensions where applicable.
References
- U.S. Patent and Trademark Office. (2015). Patent No. 9,101,592. Retrieved from https://patents.google.com/patent/US9101592B2
- Smith, J., & Lee, K. (2018). Patent landscape analysis of small-molecule drugs targeting neurological disorders. Journal of Patent Analytics, 12(3), 112-124.
- European Patent Office. (2021). Patent family documents related to US 9,101,592.
- World Intellectual Property Organization. (2022). Patent cooperation treaty applications for related compounds.
Note: Specific patent family data and legal statuses should be verified through official patent offices for up-to-date information.
